215 related articles for article (PubMed ID: 12838298)
1. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
[TBL] [Abstract][Full Text] [Related]
2. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
[TBL] [Abstract][Full Text] [Related]
6. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
7. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Forde C; McMullan R; Clarke M; Wilson RH; Plummer R; Grayson M; McDowell C; Agus A; Doran A; McAuley DF; Thomas AL; Barnes RA; Adams R; Chau I; Coyle V
Trials; 2020 May; 21(1):431. PubMed ID: 32460818
[TBL] [Abstract][Full Text] [Related]
8. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
[TBL] [Abstract][Full Text] [Related]
9. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
[TBL] [Abstract][Full Text] [Related]
10. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
Bash RO; Katz JA; Cash JV; Buchanan GR
Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
[TBL] [Abstract][Full Text] [Related]
11. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
Vedi A; Cohn R
J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
[TBL] [Abstract][Full Text] [Related]
12. Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
Papadimitris C; Dimopoulos MA; Kostis E; Papadimitriou C; Anagnostopoulos A; Alexopoulos G; Papamichael C; Gika D; Mitsibounas D; Stamatelopoulos S
Oncology; 1999; 57(2):127-30. PubMed ID: 10461059
[TBL] [Abstract][Full Text] [Related]
13. Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
Talcott JA; Yeap BY; Clark JA; Siegel RD; Loggers ET; Lu C; Godley PA
J Clin Oncol; 2011 Oct; 29(30):3977-83. PubMed ID: 21931024
[TBL] [Abstract][Full Text] [Related]
14. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
[TBL] [Abstract][Full Text] [Related]
16. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
[TBL] [Abstract][Full Text] [Related]
17. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics.
Lau RC; Doyle JJ; Freedman MH; King SM; Richardson SE
Pediatr Hematol Oncol; 1994; 11(4):417-21. PubMed ID: 7947014
[TBL] [Abstract][Full Text] [Related]
18. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.
Talcott JA; Whalen A; Clark J; Rieker PP; Finberg R
J Clin Oncol; 1994 Jan; 12(1):107-14. PubMed ID: 8270967
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
